Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Kuangli Bio-Tech Holdings Co., Ltd. (6431) Financial Statements

Kuangli Bio-Tech Holdings Co., Ltd. Financial Overview

Kuangli Bio-Tech Holdings Co., Ltd.'s market cap is currently NT$1.45B. The company's EPS TTM is NT$-1.98; its P/E ratio is -7.35; and it has a dividend yield of 7.36%. Kuangli Bio-Tech Holdings Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 377.03MNT$ 381.30MNT$ 293.37MNT$ 342.16MNT$ 358.20M
Gross ProfitNT$ 70.41MNT$ 68.32MNT$ 66.30MNT$ 68.69MNT$ 91.55M
Operating IncomeNT$ -157.48MNT$ -138.08MNT$ -113.65MNT$ -70.22MNT$ 64.69M
EBITDANT$ -92.46MNT$ -82.61MNT$ -48.85MNT$ -9.46MNT$ 107.52M
Net IncomeNT$ -193.04MNT$ -172.79MNT$ -104.16MNT$ -71.00MNT$ 55.95M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 310.17MNT$ 41.59MNT$ 90.83MNT$ 163.05MNT$ 183.03M
Total AssetsNT$ 1.19BNT$ 910.20MNT$ 1.04BNT$ 1.12BNT$ 1.25B
Total DebtNT$ 487.33MNT$ 336.82MNT$ 421.52MNT$ 349.75MNT$ 348.33M
Net DebtNT$ 278.40MNT$ 295.24MNT$ 358.30MNT$ 207.86MNT$ 186.15M
Total LiabilitiesNT$ 607.01MNT$ 450.24MNT$ 485.34MNT$ 442.81MNT$ 506.63M
Stockholders' EquityNT$ 577.39MNT$ 459.97MNT$ 557.92MNT$ 672.74MNT$ 482.27M
Cash Flow
Free Cash FlowNT$ -154.47MNT$ -82.68MNT$ -87.58MNT$ -43.46MNT$ -18.91M
Operating Cash FlowNT$ -145.33MNT$ -65.23MNT$ -62.36MNT$ -9.24MNT$ 21.69M
Investing Cash FlowNT$ 14.07MNT$ 62.25MNT$ -30.51MNT$ -3.16MNT$ -93.45M
Financing Cash FlowNT$ 314.06MNT$ -16.07MNT$ 17.52MNT$ -11.07MNT$ 121.01M

Currency in TWD

Kuangli Bio-Tech Holdings Co., Ltd. Earnings and Revenue History

-250M0250M500M-160 %-80 %0 %80 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Kuangli Bio-Tech Holdings Co., Ltd. Liabilities to Assets

0500M1B1.5B0 %20 %40 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Kuangli Bio-Tech Holdings Co., Ltd. Cash Flow

-200M-100M0100M200M300M400M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Kuangli Bio-Tech Holdings Co., Ltd. Forecast EPS vs Actual EPS

-0.7-0.6-0.5-0.4-0.3-0.2-0.1Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >